» Articles » PMID: 30357319

Fischer Rats Exhibit Maladaptive Structural and Molecular Right Ventricular Remodelling in Severe Pulmonary Hypertension: a Genetically Prone Model for Right Heart Failure

Overview
Journal Cardiovasc Res
Date 2018 Oct 26
PMID 30357319
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The ability of the right ventricle (RV) to adapt to increased afterload is the major determinant of survival in patients with pulmonary hypertension (PH). In this study, we explored the effect of genetic background on RV adaptation and survival in a rat model of severe pulmonary arterial hypertension (PAH).

Methods And Results: PH was induced by a single injection of SU5416 (SU) in age-matched Sprague Dawley (SD) or Fischer rats, followed by a 3-week exposure to chronic hypoxia (SUHx). SD and Fischer rats exhibited similar elevations in RV systolic pressure, number of occlusive pulmonary vascular lesions, and RV hypertrophy (RV/LV+S) in response to SUHx. However, no Fischer rats survived beyond 7 weeks compared with complete survival for SD rats. This high early mortality of Fischer rats was associated with significantly greater RV dilatation and reduced ejection fraction, cardiac output, and exercise capacity at 4 weeks post-SU. Moreover, microarray analysis revealed that over 300 genes were uniquely regulated in the RV in the severe PAH model in the Fischer compared with SD rats, mainly related to angiogenesis and vascular homoeostasis, fatty acid metabolism, and innate immunity. A focused polymerase chain reaction array confirmed down-regulation of angiogenic genes in the Fischer compared with SD RV. Furthermore, Fischer rats demonstrated significantly lower RV capillary density compared with SD rats in response to SUHx.

Conclusion: Fischer rats are prone to develop RV failure in response to increased afterload. Moreover, the high mortality in the SUHx model of severe PAH was caused by a failure of RV adaptation associated with lack of adequate microvascular angiogenesis, together with metabolic and immunological responses in the hypertrophied RV.

Citing Articles

Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats.

Corboz M, Nguyen T, Stautberg A, Cipolla D, Perkins W, Chapman R J Aerosol Med Pulm Drug Deliv. 2024; 37(5):241-283.

PMID: 39388691 PMC: 11502635. DOI: 10.1089/jamp.2024.0016.


Pathophysiology of the right ventricle and its pulmonary vascular interaction.

Hemnes A, Celermajer D, DAlto M, Haddad F, Hassoun P, Prins K Eur Respir J. 2024; 64(4).

PMID: 39209482 PMC: 11525331. DOI: 10.1183/13993003.01321-2024.


Right ventricular diastolic adaptation to pressure overload in different rat strains.

Axelsen J, Andersen S, Ringgaard S, Smal R, Llucia-Valldeperas A, Nielsen-Kudsk J Physiol Rep. 2024; 12(13):e16132.

PMID: 38993022 PMC: 11239975. DOI: 10.14814/phy2.16132.


3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in Pulmonary Hypertension.

Ichimura K, Boehm M, Andruska A, Zhang F, Schimmel K, Bonham S Circ Res. 2024; 135(1):60-75.

PMID: 38770652 PMC: 11584150. DOI: 10.1161/CIRCRESAHA.123.323546.


Ethanol-induced lung and cardiac right ventricular inflammation and remodeling underlie progression to pulmonary arterial hypertension.

Donovan M, Abdel-Rahman A Alcohol Clin Exp Res (Hoboken). 2024; 48(7):1250-1260.

PMID: 38710650 PMC: 11236493. DOI: 10.1111/acer.15341.


References
1.
Bogaard H, Abe K, Vonk Noordegraaf A, Voelkel N . The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest. 2009; 135(3):794-804. DOI: 10.1378/chest.08-0492. View

2.
Ormiston M, Chang C, Long L, Soon E, Jones D, Machado R . Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension. Circulation. 2012; 126(9):1099-109. DOI: 10.1161/CIRCULATIONAHA.112.110619. View

3.
Handschin C, Spiegelman B . Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006; 27(7):728-35. DOI: 10.1210/er.2006-0037. View

4.
Potus F, Ruffenach G, Dahou A, Thebault C, Breuils-Bonnet S, Tremblay E . Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. Circulation. 2015; 132(10):932-43. DOI: 10.1161/CIRCULATIONAHA.115.016382. View

5.
Abdul-Ghani M, Suen C, Jiang B, Deng Y, Weldrick J, Putinski C . Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart. Cell Res. 2017; 27(10):1195-1215. PMC: 5630684. DOI: 10.1038/cr.2017.87. View